Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy & The MS Immune System

Mar 26, 2021, 12:00 AM

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Pipeline raised $80M to pursue potential myelin restoring therapy.
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “The MS Immune System: Suppressed, Compromised, or What?”
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/